| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/26/2023 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Common Stock | 25k | $0.00 | $0 | | 05/26/2023 |
| 05/26/2023 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 30k | $1.32 | $39.6k | | 05/26/2023 |
| 05/17/2023 | Travere Therapeutics, Inc. | RTRX | Grant | | 4.5k | $0.00 | $0 | | 05/17/2023 |
| 05/17/2023 | Travere Therapeutics, Inc. | RTRX | Grant | | 13.5k | $17.11 | $231k | | 05/17/2023 |
| 05/17/2023 | NEUROCRINE BIOSCIENCES INC | NBIX | Grant | Non-Qualified Stock Option | 4.3k | $95.27 | $408.7k | | 05/17/2023 |
| 05/17/2023 | NEUROCRINE BIOSCIENCES INC | NBIX | Grant | Restricted Stock Unit | 2.1k | $0.00 | $0 | | 05/17/2023 |
| 05/01/2023 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Common Stock | 150.4k | $2.30 | $346k | | 05/01/2023 |
| 10/04/2022 | NEUROCRINE BIOSCIENCES INC | NBIX | Sale | Common Stock | 5k | $110.54 | $552.7k | | 10/04/2022 |
| 05/20/2022 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 30k | $2.01 | $60.3k | | 05/20/2022 |
| 05/20/2022 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Common Stock | 25k | $0.00 | $0 | | 05/20/2022 |
| 05/18/2022 | NEUROCRINE BIOSCIENCES INC | NBIX | Grant | Non-Qualified Stock Option | 9.7k | $84.95 | $826.1k | | 05/18/2022 |
| 05/17/2022 | Fresh Tracks Therapeutics, Inc. | VICL | Grant | Stock Option (right to buy) | 65k | $0.19 | $12.2k | | 05/17/2022 |
| 05/11/2022 | Travere Therapeutics, Inc. | RTRX | Grant | | 3k | $0.00 | $0 | | 05/11/2022 |
| 05/11/2022 | Travere Therapeutics, Inc. | RTRX | Grant | | 9k | $21.38 | $192.4k | | 05/11/2022 |
| 04/25/2022 | NEUROCRINE BIOSCIENCES INC | NBIX | Sale | Common Stock | 15k | $92.76 | $1.4M | | 04/25/2022 |
| 04/25/2022 | NEUROCRINE BIOSCIENCES INC | NBIX | Exercise | Non-Qualified Stock Option | 15k | $6.66 | $99.9k | | 04/25/2022 |
| 02/01/2022 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Stock Option (right to buy) | 20k | $3.97 | $79.4k | | 02/01/2022 |
| 10/07/2021 | NEUROCRINE BIOSCIENCES INC | NBIX | Sale | Common Stock | 5k | $105.06 | $525.3k | | 10/07/2021 |
| 06/14/2021 | Fresh Tracks Therapeutics, Inc. | VICL | Grant | Stock Option (right to buy) | 40k | $0.90 | $36k | | 06/14/2021 |
| 06/10/2021 | NEUROCRINE BIOSCIENCES INC | NBIX | Sale | Common Stock | 10k | $100.27 | $1M | | 06/10/2021 |
| 05/19/2021 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Common Stock | 25k | $0.00 | $0 | | 05/19/2021 |
| 05/19/2021 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 30k | $3.64 | $109.2k | | 05/19/2021 |
| 05/19/2021 | NEUROCRINE BIOSCIENCES INC | NBIX | Grant | Non-Qualified Stock Option | 8.8k | $92.35 | $815.7k | | 05/19/2021 |
| 05/14/2021 | Travere Therapeutics, Inc. | RTRX | Grant | | 3k | $0.00 | $0 | | 05/14/2021 |
| 05/14/2021 | Travere Therapeutics, Inc. | RTRX | Grant | | 9k | $18.27 | $164.4k | | 05/14/2021 |
| 01/26/2021 | NEUROCRINE BIOSCIENCES INC | NBIX | Sale | Common Stock | 400 | $120.00 | $48k | | 01/25/2021 |
| 01/25/2021 | NEUROCRINE BIOSCIENCES INC | NBIX | Sale | Common Stock | 1.6k | $120.03 | $192k | | 01/25/2021 |
| 12/31/2020 | Fresh Tracks Therapeutics, Inc. | VICL | Payment of Exercise | Common Stock | 6k | $0.78 | $4.7k | | 12/31/2020 |
| 09/15/2020 | Fresh Tracks Therapeutics, Inc. | VICL | Grant | Common Stock | 11.9k | $0.81 | $9.7k | | 09/15/2020 |
| 09/15/2020 | Fresh Tracks Therapeutics, Inc. | VICL | Grant | Stock Option (right to buy) | 60k | $0.80 | $48k | | 09/15/2020 |
| 09/11/2020 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Stock Option (Right to Buy) | 1.2k | $500.00 | $583.6k | | 09/11/2020 |
| 08/31/2020 | Fresh Tracks Therapeutics, Inc. | VICL | Payment of Exercise | Common Stock | 346 | $0.94 | $325.2 | | 08/31/2020 |
| 08/31/2020 | Fresh Tracks Therapeutics, Inc. | VICL | Payment of Exercise | Common Stock | 8.6k | $0.94 | $8.1k | | 08/31/2020 |
| 08/31/2020 | Fresh Tracks Therapeutics, Inc. | VICL | Exercise | Restricted Stock Units | 692 | $0.00 | $0 | | 08/31/2020 |
| 07/31/2020 | Fresh Tracks Therapeutics, Inc. | VICL | Payment of Exercise | Common Stock | 346 | $0.92 | $318.3 | | 07/31/2020 |
|